Zdrowie i gospodarka · 22/02/2012

FDA Announces Final Bioequivalence Recommendations for Specific Products

The Food and Drug Administration (FDA) has released final product-specific bioequivalence recommendations, providing guidance on designing studies to support abbreviated new drug applications (ANDAs) and making these recommendations available to the public on the FDA's website.